Cargando…

Attenuation of YAP1 can potentially target cancer stem cells to overcome drug resistance

Detalles Bibliográficos
Autores principales:	Harada, Kazuto, Song, Shumei, Ajani, Jaffer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142898/ https://www.ncbi.nlm.nih.gov/pubmed/30234141 http://dx.doi.org/10.18632/oncoscience.449

Ejemplares similares

Drug resistance and Cancer stem cells
por: Li, Yuan, et al.
Publicado: (2021)

Customization of therapy for gastroesophageal adenocarcinoma patients
por: Mizrak Kaya, Dilsa, et al.
Publicado: (2018)

Overcoming the challenges of cancer drug resistance through bacterial-mediated therapy
por: Zargar, Amin, et al.
Publicado: (2020)

Recent trend in gastric cancer treatment in the USA
por: Harada, Kazuto, et al.
Publicado: (2018)

Cutting the root: the next generation of T cells engagers against cancer stem cells to overcome drug resistance in triple-negative breast cancer
por: Zhang, Jiali, et al.
Publicado: (2023)

The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective
por: Xu, Yan, et al.
Publicado: (2019)

Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
por: Song, Shumei, et al.
Publicado: (2020)

Immunizing the Immune: Can We Overcome Influenza’s Most Formidable Challenge?
por: Ellebedy, Ali H.
Publicado: (2018)

Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells
por: Fisher, Matthew L., et al.
Publicado: (2017)

Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune microenvironment
por: Cheng, Bisheng, et al.
Publicado: (2023)

Overcoming Steroid Resistance in T Cell Acute Lymphoblastic Leukemia
por: Goossens, Steven, et al.
Publicado: (2016)

Proteomic profiling of key signatures from gastric lesions to early gastric cancer
por: Fan, Yibo, et al.
Publicado: (2021)

Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors
por: Ajani, Jaffer A, et al.
Publicado: (2018)

Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017)

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK‐rearranged lung cancer
por: Yun, Mi Ran, et al.
Publicado: (2019)

Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistance
por: Rytlewski, Jeff, et al.
Publicado: (2022)

Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer
por: HONJO, SOICHIRO, et al.
Publicado: (2014)

Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson’s disease
por: García-Muñoz, Rafael A., et al.
Publicado: (2022)

Establishing hematopoietic stem cell transplant programs; overcoming cost through collaboration
por: Al-Hashmi, Hani, et al.
Publicado: (2020)

Can Distributed Ledgers Help to Overcome the Need of Labeled Data for Agricultural Machine Learning Tasks?
por: Paulus, Stefan, et al.
Publicado: (2023)

The Hippo/YAP signaling pathway: the driver of cancer metastasis
por: Zhou, Tianxing, et al.
Publicado: (2023)

Recent advances in the management of gastric adenocarcinoma patients
por: Harada, Kazuto, et al.
Publicado: (2018)

Potential Therapeutic Strategies to Overcome Acquired Resistance to BRAF or MEK Inhibitors in BRAF Mutant Cancers
por: Corcoran, Ryan B., et al.
Publicado: (2011)

Can We Understand the Clinical Biology of Gastric Cancer and Exploit it? May be, but It is a Challenge!
por: Ajani, Jaffer A.
Publicado: (2007)

Unleashing the cure: Overcoming persistent obstacles in the translation and expanded use of hematopoietic stem cell‐based therapies
por: Talib, Sohel, et al.
Publicado: (2020)

Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
por: Cho, Yena, et al.
Publicado: (2020)

Roles of YAP in mediating endothelial cell junctional stability and vascular remodeling
por: Choi, Hyun-Jung, et al.
Publicado: (2015)

Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer
por: Kim, Youngeun, et al.
Publicado: (2017)

AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?
por: Sapio, Luigi, et al.
Publicado: (2022)

Platinum drugs and taxanes: can we overcome resistance?
por: Sazonova, Elena V., et al.
Publicado: (2021)

Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome
por: Kim, Jae-Young, et al.
Publicado: (2017)

Stem Cell Theory of Cancer: Implications for Drug Resistance and Chemosensitivity in Cancer Care
por: Tu, Shi-Ming, et al.
Publicado: (2022)

The Impact of the “Yogic Lifestyle” on Cancer Prognosis and Survival: Can we Target Cancer Stem Cells with Yoga?
por: Beri, Kavita
Publicado: (2017)

Recent advances in treating oesophageal cancer
por: Harada, Kazuto, et al.
Publicado: (2020)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Re-enforcing the strategy of targeting MEK/ERK signaling to overcome acquired resistance to third generation EGFR inhibitors
por: Zhao, Wen, et al.
Publicado: (2021)

ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer
por: Chen, Qiongrong, et al.
Publicado: (2015)

Can You Establish the Cause of This Patient's Shortness of Breath?
por: Trail, Allison, et al.
Publicado: (2023)

Overcoming EMT-driven therapeutic resistance by BH3 mimetics
por: Keitel, Ulrike, et al.
Publicado: (2014)

CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
por: Chen, Zibo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_chv066k43mb46f9ja852c9iup9